| Product Code: ETC11389217 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Fiji continued to heavily rely on imports of anticoagulants, with top exporters being Australia, New Zealand, India, Bangladesh, and the USA. Despite a slightly declining growth rate of -15.21% in 2024, the compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 6.89%. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, raising questions about potential market power and competition dynamics in the anticoagulants sector in Fiji.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Anticoagulants Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Anticoagulants Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Anticoagulants Market - Industry Life Cycle |
3.4 Fiji Anticoagulants Market - Porter's Five Forces |
3.5 Fiji Anticoagulants Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Fiji Anticoagulants Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Fiji Anticoagulants Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Fiji Anticoagulants Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Fiji Anticoagulants Market Trends |
6 Fiji Anticoagulants Market, By Types |
6.1 Fiji Anticoagulants Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Fiji Anticoagulants Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Fiji Anticoagulants Market Revenues & Volume, By Direct Oral Anticoagulants, 2021 - 2031F |
6.1.4 Fiji Anticoagulants Market Revenues & Volume, By Vitamin K Antagonists, 2021 - 2031F |
6.1.5 Fiji Anticoagulants Market Revenues & Volume, By Heparin, 2021 - 2031F |
6.2 Fiji Anticoagulants Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Fiji Anticoagulants Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Fiji Anticoagulants Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Fiji Anticoagulants Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Fiji Anticoagulants Market Revenues & Volume, By Deep Vein Thrombosis, 2021 - 2031F |
6.3.3 Fiji Anticoagulants Market Revenues & Volume, By Atrial Fibrillation, 2021 - 2031F |
6.3.4 Fiji Anticoagulants Market Revenues & Volume, By Pulmonary Embolism, 2021 - 2031F |
7 Fiji Anticoagulants Market Import-Export Trade Statistics |
7.1 Fiji Anticoagulants Market Export to Major Countries |
7.2 Fiji Anticoagulants Market Imports from Major Countries |
8 Fiji Anticoagulants Market Key Performance Indicators |
9 Fiji Anticoagulants Market - Opportunity Assessment |
9.1 Fiji Anticoagulants Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Fiji Anticoagulants Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Fiji Anticoagulants Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Fiji Anticoagulants Market - Competitive Landscape |
10.1 Fiji Anticoagulants Market Revenue Share, By Companies, 2024 |
10.2 Fiji Anticoagulants Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |